NCT01086553View on ClinicalTrials.gov

9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

471

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

May 31, 2012

Study Completion Date

December 31, 2012

Conditions
Crohn´s Disease
Interventions
DRUG

budesonide

9mg budesonide OD

DRUG

budesonide

3mg budesonide TID

Trial Locations (1)

60431

Med. Klinik I - Markus-Krankenhaus - Frankfurter Diakonie-Kliniken, Frankfurt

Sponsors
All Listed Sponsors
lead

Dr. Falk Pharma GmbH

INDUSTRY